ATG5 (human recombinant)

ATG5 (human recombinant) （订货以CAS编码或英文名称为准）

Application|Western Blot||Product Type|Proteins|Enzymes||Research Area|Cancer|Autophagy||Research Area|Cell Biology|Endomembrane System & Vesicular Trafficking|Autophagy||Research Area|Immunology & Inflammation|Autoimmunity|Lupus||Research Area|Immunology & Inflammation|Pulmonary Diseases|Asthma||Research Area|Neuroscience|Neurodegenerative Disorders|Parkinson’s Disease

创赛科技提供的所有产品仅用于科研等非医疗用途，非药品不可食用，不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料，可至下方“质量控制”中下载

编号：PC55755

分子式：C13H19N5

CAS号：477600-74-1

分子量：245.32

储存条件：-80

申请试用

货号	品牌	规格	纯度/含量	标准价	优惠价
PC55755-10mg	Medlife	10mg	≥95%	待询	登录后可见
PC55755-25mg	Medlife	25mg	≥95%	待询	登录后可见
PC55755-50mg	Medlife	50mg	≥95%	待询	登录后可见
PC55755-100mg	Medlife	100mg	≥95%	待询	登录后可见
PC55755-100µg	Medlife	EA		¥6575.00	登录后可见

中文名称：	托法替尼中间体
中文别名：	N-甲基-N-((3R,4R)-4-甲基-3-哌啶基)-7H-吡咯并[2,3-d]嘧啶-4-胺;N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺;N-甲基-N-[(3R,4R)-4-甲基-3-哌啶基]-7H-吡咯并[2,3-d]嘧啶-4-胺;托法替尼杂质M;托法替尼中间体
英文名称：	ATG5 (human recombinant)
英文别名：	N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine;tofacitinib intermediate;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-;N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine HCl;N-methyl-N-[(3R,4R)-4-methylpiperidin-3-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS号：	477600-74-1
分子式：	C13H19N5
分子量：	245.32
详细描述	Application\|Western Blot\|\|Product Type\|Proteins\|Enzymes\|\|Research Area\|Cancer\|Autophagy\|\|Research Area\|Cell Biology\|Endomembrane System & Vesicular Trafficking\|Autophagy\|\|Research Area\|Immunology & Inflammation\|Autoimmunity\|Lupus\|\|Research Area\|Immunology & Inflammation\|Pulmonary Diseases\|Asthma\|\|Research Area\|Neuroscience\|Neurodegenerative Disorders\|Parkinson’s Disease

搜索质检报告(COA)

相关产品

N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2,2'-dichloro-N- methyl-7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-amine

N-methyl-N-((3S,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d] pyrimidin-4-amine

N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-2-amine

3-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl) amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile

N2,N4-bis((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N2,N4-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine

N-methyl-N-((3R,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d] pyrimidin-4-amine

3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl) amino)piperidin-1-yl)-3-oxopropanoic acid

N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H- [4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-amine

1,3-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)propane-1,3-dione

3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl) amino)piperidin-1-yl)-3-oxopropanenitrile